• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-205-5p与21T系列的转移潜能相关:一种乳腺癌进展模型。

The microRNA-205-5p is correlated to metastatic potential of 21T series: A breast cancer progression model.

作者信息

Stankevicins L, Barat A, Dessen P, Vassetzky Y, de Moura Gallo C V

机构信息

Departamento de Genética, Universidade do Estado do Rio de Janeiro, Instituto de Biologia Roberto Alcantara Gomes, Rio de Janeiro, Brazil.

CNRS UMR 8126 «Signalisation, noyaux et innovations en cancérologie», Université Paris-Sud, Institut de Cancérologie Gustave-Roussy, Villejuif cedex, France.

出版信息

PLoS One. 2017 Mar 27;12(3):e0173756. doi: 10.1371/journal.pone.0173756. eCollection 2017.

DOI:10.1371/journal.pone.0173756
PMID:28346474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5367783/
Abstract

MicroRNA is a class of noncoding RNAs able to base pair with complementary messenger RNA sequences, inhibiting their expression. These regulatory molecules play important roles in key cellular processes including cell proliferation, differentiation and response to DNA damage; changes in miRNA expression are a common feature of human cancers. To gain insights into the mechanisms involved in breast cancer progression we conducted a microRNA global expression analysis on a 21T series of cell lines obtained from the same patient during different stages of breast cancer progression. These stages are represented by cell lines derived from normal epithelial (H16N2), atypical ductal hyperplasia (21PT), primary in situ ductal carcinoma (21NT) and pleural effusion of a lung metastasis (21MT-1 and 21MT-2). In a global microRNA expression analysis, miR-205-5p was the only miRNA to display an important downregulation in the metastatic cell lines (21MT-1; 21MT-2) when compared to the non-invasive cells (21PT and 21NT). The lower amounts of miR-205-5p found also correlated with high histological grades biopsies and with higher invasion rates in a Boyden chamber assay. This work pinpoints miR-205-5p as a potential player in breast tumor invasiveness.

摘要

微小RNA是一类非编码RNA,能够与互补的信使RNA序列进行碱基配对,从而抑制其表达。这些调节分子在包括细胞增殖、分化和对DNA损伤的反应等关键细胞过程中发挥重要作用;微小RNA表达的变化是人类癌症的一个共同特征。为了深入了解乳腺癌进展所涉及的机制,我们对从同一患者乳腺癌进展不同阶段获得的21T系列细胞系进行了微小RNA全局表达分析。这些阶段由源自正常上皮细胞(H16N2)、非典型导管增生(21PT)、原发性原位导管癌(21NT)以及肺转移胸腔积液(21MT - 1和21MT - 2)的细胞系代表。在全局微小RNA表达分析中,与非侵袭性细胞(21PT和21NT)相比,miR - 205 - 5p是唯一在转移性细胞系(21MT - 1;21MT - 2)中显示出显著下调的微小RNA。在活检中发现的较低水平的miR - 205 - 5p也与高组织学分级以及在博伊登室试验中的较高侵袭率相关。这项工作将miR - 205 - 5p确定为乳腺癌侵袭性中的一个潜在因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8182/5367783/09c461e37ac3/pone.0173756.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8182/5367783/c362ef69c1d4/pone.0173756.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8182/5367783/189d9b8335c2/pone.0173756.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8182/5367783/020866166a6f/pone.0173756.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8182/5367783/09c461e37ac3/pone.0173756.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8182/5367783/c362ef69c1d4/pone.0173756.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8182/5367783/189d9b8335c2/pone.0173756.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8182/5367783/020866166a6f/pone.0173756.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8182/5367783/09c461e37ac3/pone.0173756.g004.jpg

相似文献

1
The microRNA-205-5p is correlated to metastatic potential of 21T series: A breast cancer progression model.微小RNA-205-5p与21T系列的转移潜能相关:一种乳腺癌进展模型。
PLoS One. 2017 Mar 27;12(3):e0173756. doi: 10.1371/journal.pone.0173756. eCollection 2017.
2
Dynamically decreased miR-671-5p expression is associated with oncogenic transformation and radiochemoresistance in breast cancer.miR-671-5p 表达动态降低与乳腺癌的致癌转化和放化疗抵抗有关。
Breast Cancer Res. 2019 Aug 7;21(1):89. doi: 10.1186/s13058-019-1173-5.
3
The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.转录调节因子TBX3促进乳腺癌从非侵袭性向侵袭性进展。
BMC Cancer. 2016 Aug 23;16(1):671. doi: 10.1186/s12885-016-2697-z.
4
Human 21T breast epithelial cell lines mimic breast cancer progression in vivo and in vitro and show stage-specific gene expression patterns.人 21T 乳腺上皮细胞系在体内和体外模拟乳腺癌的进展,并显示出特定阶段的基因表达模式。
Lab Invest. 2010 Aug;90(8):1247-58. doi: 10.1038/labinvest.2010.97. Epub 2010 May 10.
5
In bone metastasis miR-34a-5p absence inversely correlates with Met expression, while Met oncogene is unaffected by miR-34a-5p in non-metastatic and metastatic breast carcinomas.在骨转移中,miR-34a-5p的缺失与Met表达呈负相关,而在非转移性和转移性乳腺癌中,Met癌基因不受miR-34a-5p的影响。
Carcinogenesis. 2017 May 1;38(5):492-503. doi: 10.1093/carcin/bgx027.
6
Role of miR-139 as a surrogate marker for tumor aggression in breast cancer.miR-139作为乳腺癌肿瘤侵袭替代标志物的作用。
Hum Pathol. 2017 Mar;61:68-77. doi: 10.1016/j.humpath.2016.11.001. Epub 2016 Nov 15.
7
MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation.微 RNA-132 在乳腺导管原位癌 (DCIS) 中经常下调,通过抑制细胞增殖发挥肿瘤抑制作用。
Pathol Res Pract. 2013 Mar;209(3):179-83. doi: 10.1016/j.prp.2012.12.002. Epub 2013 Feb 8.
8
Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.骨桥蛋白可诱导人乳腺上皮细胞的侵袭性增加及纤溶酶原激活物表达上调。
Oncogene. 1999 Jul 22;18(29):4237-46. doi: 10.1038/sj.onc.1202799.
9
miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.miR-671-5p通过下调乳腺癌中FOXM1的表达来抑制上皮-间质转化。
Oncotarget. 2016 Jan 5;7(1):293-307. doi: 10.18632/oncotarget.6344.
10
Stage of breast cancer progression influences cellular response to activation of the WNT/planar cell polarity pathway.乳腺癌进展阶段会影响细胞对WNT/平面细胞极性通路激活的反应。
Sci Rep. 2014 Sep 10;4:6315. doi: 10.1038/srep06315.

引用本文的文献

1
Recent Insights Into Breast Cancer: Molecular Pathways, Epigenetic Regulation, and Emerging Targeted Therapies.乳腺癌的最新见解:分子途径、表观遗传调控及新兴靶向治疗
Breast Cancer (Auckl). 2025 Jul 13;19:11782234251355663. doi: 10.1177/11782234251355663. eCollection 2025.
2
The role of epigenetic modifications in drug resistance and treatment of breast cancer.表观遗传修饰在乳腺癌耐药性和治疗中的作用。
Cell Mol Biol Lett. 2022 Jun 28;27(1):52. doi: 10.1186/s11658-022-00344-6.
3
Circadian Alterations Increase with Progression in a Patient-Derived Cell Culture Model of Breast Cancer.

本文引用的文献

1
Dysregulated JAK2 expression by TrkC promotes metastasis potential, and EMT program of metastatic breast cancer.TrkC对JAK2表达的失调促进了转移性乳腺癌的转移潜能和上皮-间质转化进程。
Sci Rep. 2016 Sep 22;6:33899. doi: 10.1038/srep33899.
2
Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3.抗 miR-203 通过靶向 SOCS3 抑制雌激素受体阳性乳腺癌的生长和干性。
Oncotarget. 2016 Sep 6;7(36):58595-58605. doi: 10.18632/oncotarget.11193.
3
Identification of a circulating microRNA signature to distinguish recurrence in breast cancer patients.
在一种源自患者的乳腺癌细胞培养模型中,昼夜节律改变随疾病进展而增加。
Clocks Sleep. 2021 Nov 12;3(4):598-608. doi: 10.3390/clockssleep3040042.
4
Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature.循环和细胞内微小RNA作为新辅助化疗治疗HER2阳性早期乳腺癌的预后和预测因素:文献综述
Cancers (Basel). 2021 Sep 29;13(19):4894. doi: 10.3390/cancers13194894.
5
Circulating miRNAs as early indicators of diet and physical activity response in women with metastatic breast cancer.循环微小RNA作为转移性乳腺癌女性饮食和体育活动反应的早期指标。
Future Sci OA. 2021 Mar 4;7(4):FSO694. doi: 10.2144/fsoa-2020-0208.
6
Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer.上皮间质转化和 microRNA 表达与三阴性乳腺癌中梭形和大汗腺细胞形态相关。
Sci Rep. 2021 Mar 4;11(1):5145. doi: 10.1038/s41598-021-84350-2.
7
Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE.微小 RNA-205-5p 的过表达通过下调 PRKCE 对胆囊癌细胞干细胞耐药性发挥抑制作用。
Biosci Rep. 2020 Sep 30;40(9). doi: 10.1042/BSR20194509.
8
The Regulatory Role of MicroRNAs in Breast Cancer.MicroRNAs 在乳腺癌中的调控作用。
Int J Mol Sci. 2019 Oct 6;20(19):4940. doi: 10.3390/ijms20194940.
9
3D hydrogel breast cancer models for studying the effects of hypoxia on epithelial to mesenchymal transition.用于研究缺氧对上皮-间质转化影响的3D水凝胶乳腺癌模型
Oncotarget. 2018 Aug 14;9(63):32191-32203. doi: 10.18632/oncotarget.25891.
10
miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy.微小RNA-205纳米制剂使前列腺癌细胞对化疗敏感。
Cancers (Basel). 2018 Aug 25;10(9):289. doi: 10.3390/cancers10090289.
用于区分乳腺癌患者复发情况的循环微小RNA特征的鉴定。
Oncotarget. 2016 Aug 23;7(34):55231-55248. doi: 10.18632/oncotarget.10485.
4
MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer.miRNA 表达谱分析鉴定出炎症性乳腺癌中 miR-205 的表达下调。
Mod Pathol. 2016 Apr;29(4):330-46. doi: 10.1038/modpathol.2016.38. Epub 2016 Feb 26.
5
Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis.循环微小RNA在转移性乳腺癌中的预后价值及用于转移的早期检测
Carcinogenesis. 2016 May;37(5):461-70. doi: 10.1093/carcin/bgw008. Epub 2016 Jan 19.
6
MiR-205 functions as a tumor suppressor via targeting TGF-α in osteosarcoma.在骨肉瘤中,微小RNA-205通过靶向转化生长因子-α发挥肿瘤抑制作用。
Exp Mol Pathol. 2016 Feb;100(1):160-6. doi: 10.1016/j.yexmp.2015.12.010. Epub 2015 Dec 17.
7
MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.微小RNA-96通过靶向FOXO1并调节甲状腺乳头状癌细胞中的AKT/FOXO1/Bim信号通路发挥致癌作用。
Int J Clin Exp Pathol. 2015 Sep 1;8(9):9889-900. eCollection 2015.
8
Upregulation of microRNA-96 and its oncogenic functions by targeting CDKN1A in bladder cancer.膀胱癌中通过靶向细胞周期蛋白依赖性激酶抑制剂1A上调微小RNA-96及其致癌功能
Cancer Cell Int. 2015 Nov 14;15:107. doi: 10.1186/s12935-015-0235-8. eCollection 2015.
9
Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration.《五大洲癌症发病率》:纳入标准、第十卷要点及全球癌症登记现状。
Int J Cancer. 2015 Nov 1;137(9):2060-71. doi: 10.1002/ijc.29670.
10
An overview of microRNAs.微小RNA概述
Adv Drug Deliv Rev. 2015 Jun 29;87:3-14. doi: 10.1016/j.addr.2015.05.001. Epub 2015 May 12.